# Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis

> **NCT06687382** · PHASE2 · RECRUITING · sponsor: **Mikrobiomik Healthcare Company S.L.** · enrollment: 81 (estimated)

## Conditions studied

- Diverticulitis
- Diverticulitis of Sigmoid

## Interventions

- **BIOLOGICAL:** MBK-01
- **BIOLOGICAL:** MBK-01

## Key facts

- **NCT ID:** NCT06687382
- **Lead sponsor:** Mikrobiomik Healthcare Company S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 81 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06687382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06687382, "Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06687382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*